Checkpoint Therapeutics (CKPT) Insider Trading & Ownership $3.13 -0.05 (-1.57%) Closing price 04:00 PM EasternExtended Trading$3.24 +0.12 (+3.67%) As of 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Checkpoint Therapeutics (NASDAQ:CKPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$2.25 M Get CKPT Insider Trade Alerts Want to know when executives and insiders are buying or selling Checkpoint Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CKPT Insider Buying and Selling by Quarter Checkpoint Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/10/2025James F Oliviero IIICEOSell10,331$3.15$32,542.65 2/7/2025James F Oliviero IIICEOSell9,233$3.41$31,484.53 2/6/2025William Garrett GrayCFOSell74,110$3.67$271,983.70 12/19/2024James F Oliviero IIICEOSell220,230$3.38$744,377.40 12/18/2024William Garrett GrayCFOSell268,432$4.01$1,076,412.32 6/26/2024James F Oliviero IIICEOSell24,610$2.05$50,450.50 6/26/2024William Garrett GrayCFOSell13,038$2.06$26,858.28 2/28/2024James F Oliviero IIICEOSell5,894$2.06$12,141.64 2/28/2024William Garrett GrayCFOSell2,035$2.07$4,212.45 (Data available from 1/1/2013 forward) CKPT Insider Trading Activity - Frequently Asked Questions Who is on Checkpoint Therapeutics's Insider Roster? The list of insiders at Checkpoint Therapeutics includes James F Oliviero III, and William Garrett Gray. Learn more on insiders at CKPT. What percentage of Checkpoint Therapeutics stock is owned by insiders? 2.10% of Checkpoint Therapeutics stock is owned by insiders. Learn more on CKPT's insider holdings. Which Checkpoint Therapeutics insiders have been selling company stock? The following insiders have sold CKPT shares in the last 24 months: James F Oliviero III ($948,128.92), and William Garrett Gray ($1,414,365.24). How much insider selling is happening at Checkpoint Therapeutics? Insiders have sold a total of 660,464 Checkpoint Therapeutics shares in the last 24 months for a total of $2,362,494.16 sold. Checkpoint Therapeutics Key ExecutivesMr. James F. Oliviero III (Age 48)C.F.A., President, CEO & Director Compensation: $921.59k3 recent tradesMr. William Garrett Gray (Age 37)CFO, Corporate Secretary & Treasurer Compensation: $409.12k2 recent trades More Insider Trading Tools from MarketBeat Related Companies AnaptysBio Insider Buying Kura Oncology Insider Buying CorMedix Insider Buying ORIC Pharmaceuticals Insider Buying Rapport Therapeutics Insider Buying Septerna Insider Buying Precigen Insider Buying Stoke Therapeutics Insider Buying Cullinan Therapeutics Insider Buying Xeris Biopharma Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:CKPT) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Checkpoint Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Checkpoint Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CKPT Stock Alerts